BFG
NVO

Bleakley Financial Group’s Novo Nordisk NVO Stock Holding History

Bleakley Financial Group’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.44M Sell
50,970
-24,648
-33% -$1.06M 0.03% 420
2026
Q1 		$2.78M Buy
75,618
+13,075
+21% +$620K 0.04% 324
2025
Q4 		$3.18M Buy
62,543
+1,221
+2% +$62.4K 0.06% 269
2025
Q3 		$3.4M Sell
61,322
-4,759
-7% -$279K 0.08% 208
2025
Q2 		$4.56M Sell
66,081
-4,637
-7% -$315K 0.12% 157
2025
Q1 		$4.91M Buy
70,718
+625
+0.9% +$51.6K 0.16% 127
2024
Q4 		$6.03M Sell
70,093
-9,086
-11% -$983K 0.18% 94
2024
Q3 		$9.43M Sell
79,179
-41,828
-35% -$5.58M 0.29% 56
2024
Q2 		$17.3M Sell
121,007
-31,086
-20% -$4.12M 0.5% 34
2024
Q1 		$19.5M Buy
152,093
+28,222
+23% +$3.36M 0.57% 28
2023
Q4 		$12.8M Buy
123,871
+2,769
+2% +$274K 0.41% 44
2023
Q3 		$11M Buy
121,102
+51,952
+75% +$4.58M 0.39% 51
2023
Q2 		$5.6M Buy
69,150
+5,490
+9% +$448K 0.17% 109
2023
Q1 		$5.07M Buy
63,660
+11,928
+23% +$846K 0.17% 109
2022
Q4 		$3.5M Buy
+51,732
New +$3.03M 0.13% 157

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bleakley Financial Group's NVO Position: Q2 2026 in Review

Bleakley Financial Group reduced its Novo Nordisk (NVO) stake by 33% in Q2 2026, selling an estimated $1.06M and leaving 50,970 shares worth $2.44M. The position accounts for 0.03% of the portfolio, ranked #420.

Bleakley Financial Group first reported a position in NVO in Q4 2022 and has held it in 15 quarters since. The position peaked at $19.5M in Q1 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Bleakley Financial Group held 50,970 shares of Novo Nordisk worth $2.44M as of Q2 2026.
  • Bleakley Financial Group sold 24,648 Novo Nordisk shares in Q2 2026, an estimated $1.06M.
  • Novo Nordisk made up 0.03% of Bleakley Financial Group's portfolio in Q2 2026, its #420 holding.
  • Bleakley Financial Group first reported a position in Novo Nordisk in Q4 2022 and has held it in 15 quarters since.
  • Bleakley Financial Group's Novo Nordisk position peaked at $19.5M in Q1 2024.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Bleakley Financial Group's 13F filing for Q2 2026, filed 5 Aug 2026.